ZALEH PARHAM: Open Payments
NPI 1134459670 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 20 payments from 10 companies in 2025. Trend: 2023 $197 · 2024 $818 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $189 |
| Novo Nordisk Inc | 5 | $107 |
| PFIZER INC. | 2 | $44 |
| Lilly USA, LLC | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Viatris Specialty LLC | 2 | $35 |
| Amgen Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: FREESTYLE LIBRE 3, Wegovy, MOUNJARO, ZORYVE, YUPELRI, OTEZLA, GVOKE HYPOPEN, PAXLOVID.
Industry payments across WA — which companies pay providers there.
